Biomedical Engineering Reference
In-Depth Information
Acknowledgments
The author would like to thank the University of Kashan and Royan Institute for financial
support. The author acknowledges Dr Baharvand for his helpful comments and promotion
of this work.
References
[1]
Ferreira L, JM Karp, L Nobre and R Langer (2008). New opportunities: the use of nanotech-
nologies to manipulate and track stem cells. Cell Stem Cell 3: 136-146.
[2]
Kingham E and ROC Oreffo (2013). Embryonic and induced pluripotent stem cells: under-
standing, creating, and exploiting the nano-niche for regenerative medicine. ACS Nano 7:
1867-1881.
[3]
Peng L-H, S-Y Tsang, Y Tabata and J-Q Gao (2012). Genetically-manipulated adult stem cells
as therapeutic agents and gene delivery vehicle for wound repair and regeneration. Journal of
Controlled Release 157: 321-330.
[4]
Santos JL, D Pandita, J Rodrigues, AP Pego, PL Granja and H Tomás (2011). Non-viral gene
delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engi-
neering and regeneration. Current Gene Therapy 11: 46-57.
[5]
Ferreira L (2009). Nanoparticles as tools to study and control stem cells. Journal of Cellular
Biochemistry 108: 746-752.
[6]
Burande MA and AR Burande (2012 ). Nanoparticle and stem cell nanotechnology: interdisci-
plinary research area involving pharmacology and anatomy. International Journal of Recent
Trends in Science and Technology 1: 50-58.
[7]
Pushp P, R Kaur, HT Lee and MK Gupta (2013). Nanoparticles for gene delivery into stem
cells and embryos. In
Multifaceted Development and Application of Biopolymers for Biology,
Biomedicine and Nanotechnology
, PK Dutta and J Dutta (eds). Springer-Verlag: Berlin;
51-86.
[8]
Seo S-J, T-H Kim, S-J Choi, J-H Park, IB Wall and H-W Kim (2013). Gene delivery techniques
for adult stem cell-based regenerative therapy. Nanomedicine 8: 1875-1891.
[9]
Maia J, T Santos, S Aday, F Agasse, L Cortes, JO Malva, L Bernardino and L Ferreira (2010).
Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic
acid-loaded nanoparticles. ACS Nano 5: 97-106.
[10]
Ku B, J-e Kim, BH Chung and BG Chung (2013). Retinoic acid-polyethyleneimine complex
nanoparticles for embryonic stem cell-derived neuronal differentiation. Langmuir 29: 9857-9862.
[11]
Benoit DS and ME Boutin (2012). Controlling mesenchymal stem cell gene expression using
polymer-mediated delivery of siRNA. Biomacromolecules 13: 3841-3849.
[12]
Yau WWY, P-O Rujitanaroj, L Lam and SY Chew (2012). Directing stem cell fate by controlled
RNA interference. Biomaterials 33: 2608-2628.
[13]
Shah DA, S-J Kwon, SS Bale, A Banerjee, JS Dordick and RS Kane (2011). Regulation of
stem cell signaling by nanoparticle-mediated intracellular protein delivery. Biomaterials 32:
3210-3219.
[14]
Mahor S, E Collin, BC Dash and A Pandit (2011). Controlled release of plasmid DNA from
hyaluronan nanoparticles. Current Drug Delivery 8: 354-362.
[15]
Chen X-A, L-J Zhang, Z-J He, W-W Wang, B Xu, Q Zhong, X-T Shuai, L-Q Yang and Y-B
Deng (2011). Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles
for gene delivery into rat mesenchymal stem cells. International Journal of Nanomedicine 6:
843-853.
[16]
Hosseinkhani H, M Hosseinkhani, NP Gabrielson, DW Pack, A Khademhosseini and H
Kobayashi (2008). DNA nanoparticles encapsulated in 3D tissue-engineered scaffolds enhance
osteogenic differentiation of mesenchymal stem cells. Journal of Biomedical Materials Research
Part A 85A: 47-60.
